Journal: Antioxidants (Basel, Switzerland)
Article Title: Antioxidant and Anti-Apoptotic Neuroprotective Effects of Cinnamon in Imiquimod-Induced Lupus.
doi: 10.3390/antiox13070880
Figure Lengend Snippet: Figure 1. (A): Schematic representation of the experimental design, showing imiquimod treatment and cinnamon administration for the different groups: sham, sham treated with cinnamon (Sham Cinna), imiquimod-induced lupus (Lupus), imiquimod-induced lupus with cinnamon treatment (Lupus Cinna), and imiquimod-induced lupus with cinnamon administration starting 2 weeks before induction and continued after induction (Cinna Lupus Cinna). (B) Hippocampal immunofluorescence (scale bars 15 µm, magnification ×100) with quantification of IgG accumulation in the different groups. (C,D) Antibody array (C) with heatmap (D) of oxidative stress markers, TLR7 and MYD88, for the different groups. (E–K) Quantification of p-NRF/NRF, p-FOXO3/FOXO3, TLR7/β-actin, MYD88/β- actin, p-NOS3/NOS3, SOD1/β-actin, and SOD2/β-actin. (L,M) Western blot and quantification of p-FOXO3/FOXO3. (N,O) Western blot and quantification of p-NRF/NRF. a.u.: arbitrary units. * p < 0.05 and ** p < 0.01.
Article Snippet: The additional primary antibodies were: anti-Toll-like receptor 7 TLR7 (ab24184; Abcam, Cambridge, UK), anti-Caspase 3 (ab13847; Abcam, Cambridge, UK), anti-Caspase 8 (ab108333; Abcam, Cambridge, UK), anti-BID (ab62469; Abcam, Cambridge, UK), t-BID (ab10640; Abcam, Cambridge, UK), MyD88 (NB100-56698SS) (Novus Biologicals Bio-Techne, Minneapolis, MN, USA), NOS3 (sc-654), 8-OHDG (sc-66036), SOD1 (sc-101523), SOD2 (sc133134) (Santa Cruz Biotechnology, Dallas, TX, USA), and NOS3 (Ser1177) (#9571) (Cell Signaling Technology, Danvers, MA, USA).
Techniques: Immunofluorescence, Ab Array, Western Blot